Carpmaels & Ransford

Firm overview:

Carpmaels & Ransford is highly regarded by its peers, which consider it to have a top-tier patent practice; market feedback includes that the firm has an “enviable client list” and is “very good at oppositions”. Carpmaels combines litigation with a well-established prosecution practice, as well as transactional expertise, to offer a full IP service to clients. The firm is particularly strong on the life sciences side, and has represented clients before the Unified Patent Court (UPC) since its inception.

Team overview:

Carpmaels’ patent team has particular strength across biologics, pharmaceuticals, chemistry and energy storage. The partnership brings together prosecution, opposition and litigation capability, giving clients a joined-up service across the full patent lifecycle.

Kevin Cordina is a recent big-name arrival at the firm, having left Simmons & Simmons where he was head of UK IP. Cordina advises on all aspects of patent procurement, portfolio management, enforcement and defence, as well as handling cases before the European Patent Office (EPO) and UPC.

Key members of the team serving the firm’s life sciences client base include Daniel Wise, who specialises in biologics and pharmaceuticals, and spends much of his time handling EPO opposition and UPC revocation proceedings.